Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
Go back to Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.27 +0.04 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.23 | 52 Week High | $16.89 | |||
| Open | $4.20 | 52 Week Low | $7.35 | |||
| Day High | $4.35 | P/E | N/A | |||
| Day Low | $4.17 | EPS | $-2.35 | |||
| Volume | 1,193,446 | |||||
